| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Akio Ohta | |
| Michail Sitkovsky | |||
| P2860 | cites work | Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies | Q22008835 |
| Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor | Q24323906 | ||
| Adoptive immunotherapy for cancer: building on success | Q24546258 | ||
| Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury | Q24796780 | ||
| International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 | ||
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Hypoxia in cancer: significance and impact on clinical outcome | Q28298305 | ||
| Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6 | Q28361896 | ||
| Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion | Q28507222 | ||
| Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury | Q28585044 | ||
| Adenosine receptors in regulation of dendritic cell differentiation and function | Q28586835 | ||
| A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice | Q28594915 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction | Q30312207 | ||
| Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease | Q30437360 | ||
| A2B adenosine receptor gene deletion attenuates murine colitis | Q30438772 | ||
| Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation | Q30442067 | ||
| Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition | Q30443210 | ||
| The A2B adenosine receptor protects against inflammation and excessive vascular adhesion | Q30477474 | ||
| Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. | Q33537215 | ||
| Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen | Q33756662 | ||
| Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor | Q33933737 | ||
| T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine | Q34578972 | ||
| A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice | Q34826208 | ||
| Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia | Q34842221 | ||
| A2A adenosine receptor protects tumors from antitumor T cells. | Q35016529 | ||
| Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis | Q35546429 | ||
| Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. | Q35698535 | ||
| Adenosine A2a receptors induce heterologous desensitization of chemokine receptors | Q35849780 | ||
| Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway | Q36301576 | ||
| Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors | Q36380776 | ||
| Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis | Q36497075 | ||
| Immune resistance orchestrated by the tumor microenvironment | Q36593747 | ||
| Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine | Q36691126 | ||
| Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice | Q36844160 | ||
| Creating immune privilege: active local suppression that benefits friends, but protects foes. | Q37026641 | ||
| Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. | Q37208648 | ||
| Immune therapy for cancer | Q37324793 | ||
| Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism | Q38337539 | ||
| Cyclic AMP-dependent protein kinase as a part of the possible down-regulating pathway in the antigen receptor-regulated cytotoxic T lymphocyte conjugate formation and granule exocytosis | Q39274134 | ||
| Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities | Q44081143 | ||
| Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo | Q44947121 | ||
| The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? | Q46516132 | ||
| HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak | Q46726814 | ||
| 1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism | Q46891800 | ||
| The Antiinflammatory Effects of Methotrexate are Mediated by Adenosine | Q72025640 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 501-506 | |
| P577 | publication date | 2009-06-17 | |
| P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
| P1476 | title | The adenosinergic immunomodulatory drugs | |
| P478 | volume | 9 |
| Q34100615 | A novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesions |
| Q85820879 | Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8(+) T-cell priming capacity |
| Q42059361 | Adenosine and its receptors as therapeutic targets: An overview |
| Q40536536 | Adenosine modulates Toll-like receptor function: basic mechanisms and translational opportunities. |
| Q37948081 | Adenosine receptor targeting in health and disease |
| Q34099143 | Caffeine acts via A1 adenosine receptors to disrupt embryonic cardiac function |
| Q50224587 | Ectonucleotidase inhibitors: a patent review (2011-2016). |
| Q36458172 | Endogenous Inhibitors of Kidney Inflammation |
| Q39396959 | Fall in oxygen tension of culture medium stimulates the adenosinergic signalling of a human T cell line. |
| Q38050028 | Inflammation, pain, and pressure--purinergic signaling in oral tissues |
| Q54112980 | Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection. |
| Q61398598 | Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD |
| Q37768190 | Modifying radiation damage |
| Q55340359 | Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases. |
| Q92404916 | Purinergic Signaling in Pulmonary Inflammation |
| Q38263455 | Purinergic signalling and immune cells |
| Q35897785 | Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP. |
| Q34054895 | Substructure-based virtual screening for adenosine A2A receptor ligands |
| Q42238591 | The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. |
| Q34125107 | The guanosine-adenosine interaction exists in vivo |
| Q37920537 | Therapeutic potential of adenosine analogues and conjugates |
| Q37677794 | Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium |
Search more.